Home › Trial NCT01300026
AMG 319 Lymphoid Malignancy FIH
- Trial IDNCT01300026
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorAmgen
- Enrollment28
- Start date2011-04
- ConditionsCancer · Chronic Lymphocytic Leukemia · Diffuse Large Cell Lymphoma · Hematologic Malignancies · Hematology · Leukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.